An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.
2 National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China.
3 School of Medicine, Xiamen University, Xiamen, China.
4 Department of Hematology, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.
5 Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China.
6 Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
1 Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.
2 National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China.
3 School of Medicine, Xiamen University, Xiamen, China.
4 Department of Hematology, Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China.
5 Laboratory of Surgical Oncology, Peking University People's Hospital, Beijing, China.
6 Laboratory of Surgical Oncology, Beijing Key Laboratory of Colorectal Cancer Diagnosis and Treatment Research, Beijing, China.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
Editorial on the Research Topic The Molecular Basis of Somatic Evolution
References
McGranahan N, Swanton C. Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution. Cancer Cell (2015) 27:15–26. doi: 10.1016/j.ccell.2014.12.001
-
DOI
-
PubMed
Persi E, Wolf Y, Horn D, Ruppin E, Demichelis F, Gatenby R, et al. . Mutation-Selection Balance and Compensatory Mechanisms in Tumour Evolution. Nat Rev Genet (2021) 22:251–62. doi: 10.1038/s41576-020-00299-4
-
DOI
-
PubMed
Koh G, Degasperi A, Zou X, Momen S, Nik-Zainal S. Mutational Signatures: Emerging Concepts, Caveats and Clinical Applications. Nat Rev Cancer (2021) 21:619–37. doi: 10.1038/s41568-021-00377-7
-
DOI
-
PubMed
Guo J, Zhou Y, Xu C, Chen Q, Sztupinszki Z, Börcsök J, et al. . Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers. Cancer Res (2021) 81:4205–17. doi: 10.1158/0008-5472.Can-21-0086
-
DOI
-
PMC
-
PubMed
Helleday T, Eshtad S, Nik-Zainal S. Mechanisms Underlying Mutational Signatures in Human Cancers. Nat Rev Genet (2014) 15:585–98. doi: 10.1038/nrg3729
-
DOI
-
PMC
-
PubMed